Prelude Capital Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-40,000
Closed -$344K 1129
2023
Q3
$344K Buy
+40,000
New +$284K 0.02% 603

Other funds holding ASPN

Prelude Capital Management's ASPN Position: Q2 2026 in Review

Prelude Capital Management opened a new position in Aspen Aerogels (ASPN) in Q2 2026: 13,911 shares worth $88.2K. The stake represents 0.01% of the portfolio and ranks #1128 among its holdings. This is a return to the name: Prelude Capital Management previously reported a position in ASPN as recently as Q3 2025.

Prelude Capital Management first reported a position in ASPN in Q3 2019 and has held it in 10 quarters since. The position peaked at $324K in Q4 2022. 179 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • Prelude Capital Management held 13,911 shares of Aspen Aerogels worth $88.2K as of Q2 2026.
  • Aspen Aerogels was a new Prelude Capital Management position in Q2 2026.
  • Aspen Aerogels made up 0.01% of Prelude Capital Management's portfolio in Q2 2026, its #1128 holding.
  • Prelude Capital Management first reported a position in Aspen Aerogels in Q3 2019 and has held it in 10 quarters since.
  • Prelude Capital Management's Aspen Aerogels position peaked at $324K in Q4 2022.
  • 179 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.